Identity
- Type
- startup
- Country label
- USA / UK
- HQ country
- USA
- Founding country
- USA
- Parent
- not in the notes
- Parent country
- not in the notes
- Country basis
- press dateline
Where this comes from
Convention D1: a dual label, HQ first, when the HQ, founding or parent country differ.
Models by Class
Models
ModelClassOpennessParametersReleased
Links
Organisation
Boltz PBCstartup, USA / UK
Who Runs It
PfizerContract signed, 8 Jan 2026
PfizerContract signed, 8 Jan 2026Scores
| Benchmark | Model | Score | Who ran it | Setting |
|---|---|---|---|---|
| FEP+/OpenFE binding affinity benchmark | Boltz-2 | 0.62 Pearson r | vendor-reported | About 0.62; about 1,000x faster than FEP |
Where this comes from
Every recorded score of this organisation's models, with who ran it. Scores from different settings are not directly comparable.
Sources
- Boltz and Pfizer Announce Strategic Collaboration for AI Drug Discovery boltz.bio https://boltz.bio/pfizer-partnership
- Boltz Announces Collaboration with GSK to Deploy Biomolecular AI Models for Drug Discovery boltz.bio https://boltz.bio/gsk-partnership
- Our Vision: The Future We Are Building at Boltz boltz.bio https://boltz.bio/manifesto
- Boltz Careers jobs.gem.com https://jobs.gem.com/boltz
- intuitionlabs.ai/articles/open-source-ai-drug-discovery-boltz-... https://intuitionlabs.ai/articles/open-source-ai-drug-discovery-boltz-pfizer
- GitHub - jwohlwend/boltz: Official repository for the Boltz biomolecular interaction models github.com https://github.com/jwohlwend/boltz
To cite this page: Project AURION, AI Use-Cases Research & Innovation, "Boltz PBC", https://aurion.semai.id/organisations/boltz/, records of October 2026.